https://de.marketscreener.com/kurs/aktie/AMYLYX-PHARMACEUTICALS-IN-131408793/news/Amylyx-Pharmaceuticals-Inc-gibt-erste-Ergebnisse-der-globalen-Phase-3-Studie-PHOENIX-mit-AMX0035-b-46129002/?utm_source=telegram&utm_medium=social&utm_campaign=share